Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia-Reference-Cited by-同舟云学术

Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia

Published:2003-06 Issue:6 Volume:3 Page:901-907
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Fujisaki Tomoaki,Otsuka Teruhisa,Gondo Hisashi,Okamura Takashi,Niho Yoshiyuki,Ohhinata Akira,Abe Fuminori

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference23 articles.

1. A new consistent chromosome abnormality in chronic myelogeneous leukaemia detected by quinacrine fluorescence and Giemsa staining;Rowley;Nature,1973

2. Philadelphia chromosome breakpoints are clustered within a limited region, bcr, on chromosome 22;Groffen;Cell,1984

3. The chronic myelogeneous leukemia-specific p210 protein is the product of the bcr–abl hybrid gene;Ben-Neriah;Science,1986

4. Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study;Barnett;Blood,1994

5. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level;Udomsakdi;Proc. Natl. Acad. Sci. U. S. A.,1992

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bestatin Inhibits Cell Growth, Cell Division, and Spore Cell Differentiation in Dictyostelium discoideum;Eukaryotic Cell;2012-04

2. Peptidomimetics and metalloprotease inhibitors as anticancer drugs;Science in China Series B: Chemistry;2009-05

3. The ectopeptidases dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN) and their related enzymes as possible targets in the treatment of skin diseases;Frontiers in Bioscience;2008

4. Inhibitors of Dipeptidyl Peptidase IV and Aminopeptidase N Target Major Pathogenetic Steps in Acne Initiation;Journal of Investigative Dermatology;2007-05

5. Long-term cytogenetic remission with ubenimex monotherapy in a case of chronic myeloid leukemia;Anti-Cancer Drugs;2004-08